ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression

Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center), Mazhar Adli(Broad Institute), Lindsay M. LaFave(Memorial Sloan Kettering Cancer Center), Jie Gao(Howard Hughes Medical Institute), Todd Hricik(Memorial Sloan Kettering Cancer Center), Alan H. Shih(Memorial Sloan Kettering Cancer Center), Suveg Pandey(Memorial Sloan Kettering Cancer Center), Jay P. Patel(Memorial Sloan Kettering Cancer Center), Young Rock Chung(Memorial Sloan Kettering Cancer Center), Richard P. Koche(Broad Institute), Fabiana Perna(Memorial Sloan Kettering Cancer Center), Xinyang Zhao(University of Alabama at Birmingham), Jordan E. Taylor(Broad Institute), Christopher Y. Park(Memorial Sloan Kettering Cancer Center), Martin Carroll(University of Pennsylvania), Ari Melnick(Cornell University), Stephen D. Nimer(University of Miami), Jacob D. Jaffe(Broad Institute), Iannis Aifantis(Memorial Sloan Kettering Cancer Center), B Bernstein(Broad Institute), Ross L. Levine(Memorial Sloan Kettering Cancer Center)
Cancer Cell
August 1, 2012
10.1016/j.ccr.2012.06.032
Cited by 589Open Access
Full Text

Abstract

Related Papers

A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells
B Bernstein, Tarjei S. Mikkelsen, Xiaohui Xie et al.|Cell|2006|5.4k
The polycomb group protein EZH2 is involved in progression of prostate cancer
Sooryanarayana Varambally, Saravana M. Dhanasekaran, Ming Zhou et al.|Nature|2002|2.7k
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Thomas Ernst, Andrew Chase, Joannah Score et al.|Nature Genetics|2010|1.1k
Germline BAP1 mutations predispose to malignant mesothelioma
Joseph R. Testa, Mitchell Cheung, Jianming Pei et al.|Nature Genetics|2011|1.1k
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
Matthew J. Bott, Marie Brevet, Barry S. Taylor et al.|Nature Genetics|2011|730